We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru
Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru
Sinopharm has announced that it will launch another phase 3 trial of its experimental COVID-19 vaccine candidate, this time in Peru, following a greenlight from the Peruvian health regulator.